<div>
  <ul>
    <li>
      <p>
        Toronto-based AI-powered healthcare company HEALWELL AI has announced a bought-deal private placement to raise USD 16 million consisting of ~12 million units at a price of USD 1.35 per share. The offering is expected to close by May 24, 2024, subject to regulatory approvals.
      </p>
    </li>
    <li>
      <p>
        The company has entered an agreement with Clarus Securities and Eight Capital, which represents a syndicate of underwriters. Each unit comprises a Class A subordinate voting share and half of one common share purchase warrant of the company.&nbsp;
      </p>
    </li>
    <li>
      <p>
        The company intends to use the net proceeds from the offering toward growth strategies and for general corporate and working capital purposes.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://company.sp-edge.com/GlobeNewswire%20News%20Room">
      Press release
    </a>
    <b></b>
  </p>
</div>


Preventive Healthcare

<div>
 <p>AI-powered healthcare firm HEALWELL AI, based in Toronto, has announced a bought-deal private placement to raise USD 16 million. This consists of about 12 million units priced at USD 1.35 per share, with closure expected by May 24, 2024, depending on regulatory approvals.</p>
 <p>HEALWELL AI has entered into an agreement with Clarus Securities and Eight Capital, a syndicate of underwriters. Each unit in the agreement consists of a Class A subordinate voting share and half of one common share purchase warrant of the company.</p>
 <p>The company has plans to use the net proceeds from this offering towards its growth strategies and for routine corporate and working capital needs.</p>
 
</div>

HEALWELL AI raises USD 16 Million via bought-deal private placement

PROMINENT_CATEGORY

<div>
 
 <p>Thyme Care, a chronic care-focused management company has established Enhanced Supportive Care services, an online palliative care program to support members and caregivers. Julia Frydman has been named the program's first medical director for palliative care.</p>
 <p>This innovative program aims to help eligible patients and their caregivers navigate the challenges of cancer, offering assistance with physical and psychological symptoms. It features detailed medical decision-making advice, alignment of patient goals and values with treatment plans, regular interaction with patient oncologists, and clinical oversight and mentoring for the care team. Thyme Care is also looking to increase its clinician workforce by hiring nurse practitioners by year-end.</p> 
 
</div>

Thyme Care launches virtual palliative care program; appoints medical director

<div>
<p>Livara Health, previously known as SpineZone, is a virtual musculoskeletal (MSK) care management platform. It has successfully procured USD 15 million in a Series B funding round, with A1 Health Ventures, Polaris Partners, Providence Ventures, and other investors leading the contribution. This funding has increased Livara Health's total capital raised to USD 27 million. The newly acquired funds are planned to be used for augmenting the company's technological and clinical proficiencies.</p>
</div>

Livara Health raises USD 15 million in Series B funding to enhance platform capabilities

<div>
 
 <p>Biotricity, a remote patient monitoring company, has collaborated with two notable neurology and sleep apnea diagnostic companies for enhanced cardiac diagnostics. This move enables the provision of advanced holistic screenings for sleep or neurological disorder patients, facilitating early detection and better disease management for improved quality of life.</p>
 
</div>

Biotricity partners with two home-based diagnostic companies to extend solutions

ANALYST_QUICK_TAKE

<div>
 
 <p>Midi Health, a women's midlife health care provider, has successfully raised USD 60 million in a Series B funding round. Emerson Collective led the initiative and was joined by participants like Google Ventures, Memorial Hermann, SemperVirens, Felicis, Icon Ventures, Black Angel Group, and Gingerbread Capital. With this recent round, the total funds amassed by Midi Health sum up to USD 100 million.</p>
 
 <p>The fresh capital will be used to widen insurance coverage and bring on board and train additional 150 clinicians by this year's end. Midi Health plans to diversify its service offerings, increase awareness on midlife women's healthcare, and expand its operations to provide care for more than 1 million women per year by 2029.&nbsp;</p>
 
</div> <p><b>Analyst QuickTake:<br>
 </b> The company is leading the way in delivering expert and insurance-friendly healthcare to women in perimenopause and menopause stages. Last <a href="https:<br>
//sp-edge.com/updates/23220"> October </a> , it announced that it would expand its virtual care clinic to employers in all 50 states beginning in January 2024. In <a href="https:<br>
//sp-edge.com/updates"> March 2024 </a> , the company partnered with Neurotrack to help women determine whether brain fog symptoms are indicative of menopause or signs of severe cognitive impairment such as early dementia.&nbsp;</p>

Midi Health raises USD 60 million in Series B funding to expand services and operations

<div>
 <p>Biolinq, a developer of medical devices, has secured a funding of USD 58 million in a round led by Alpha Wave Ventures, with contributions from Niterra, Pegasus Tech Ventures, Taisho Pharmaceutical, and other investors. The company's total funding now amounts to USD 254.3 million.</p>
 <p>The newly raised finances will be utilized to fund a vital clinical trial in the US, aimed at evaluating Biolinq's exclusive intradermal glucose sensor. The trial is expected to wrap up within this year and will subsequently lead to an FDA submission.</p>
</div> <p><b>Analyst QuickTake:<br>
 </b> Biolinq is in the race to compete with Know Labs, which introduced non-invasive CGM technology to the market. In <a href="https:<br>
//sp-edge.com/updates/27010"> February 2024 </a> , Know Labs unveiled KnowU, a wearable non-invasive CGM, and is also advancing toward FDA clinical trials.</p>

Biolinq raises USD 58 million to advance wearable biosensors into clinical trials

<div>
 <p>Remote monitoring firm, Movano Health, has generated USD 24 million in funding through a private placement of 45 million units. Participants in this round included a top-tier medical device firm, in addition to members of Movano's management team and board of directors. This puts the company's total funds to date at USD 59.7 million.</p>
 <p>These newly acquired funds are intended to offset operational expenditures and address other general business requirements. Taking into account the company's existing financial condition and proceeds from this round, Movano's existing operating plan is expected to be funded until 2025.</p>
 
</div>

Movano Health raises USD 24 million via private placement for operational expenses

<div>
 <p>Population health management platform provider, HealthArc, has successfully raised USD 5 million in a funding round. This investment was spearheaded by ScOp Venture Capital, with additional funding from entities like Original Capital, Dream Capital, Correlation Ventures, and a number of angel investors. With this latest funding round, the total capital raised by HealthArc now stands at USD 5.55 million.</p>
 <p>The new liquidity will be allocated to the growth and development of HealthArc's care management platform.</p>
 <p>HealthArc's offerings include a digital care management platform which features virtual programs. These encompass remote patient monitoring, chronic care management, and behavioral health integration. Remarkably, the platform is compatible with over 50 medical devices used to manage various chronic conditions. This allows for a unified data experience for both patients and healthcare providers.</p>
</div>

HealthArc raises USD 5 million in growth funding to develop platform

<div>

 <p>Eko Health, a company focused on digital healthcare particularly for heart and lung diseases, has successfully gained FDA 510(k) clearance for their AI-backed cardiac tool known as Eko Low Ejection Fraction Tool (ELEFT). This tool aims to aid providers in early detection of low ejection fraction, which is a major indication of heart failure.</p>
 <p>ELEFT operates in an efficient manner allowing healthcare providers to detect low ejection fraction within just 15 seconds during a routine medical check using an Eko stethoscope. The tool is set to be an integral part of Eko's existing SENSORA Cardiac Early Detection Platform. This platform already houses a variety of FDA-approved algorithms for detecting AFib and structural heart murmurs.</p>

</div>

Eko Health receives FDA clearance for AI-enabled cardiac tool

<div>
 
 <p>Midi Health, a women's health clinic, is partnering with Neurotrack, a cognitive assessment company, to determine if brain fog symptoms are due to menopause or if they're an early indicator of dementia in women. </p>
 <p>This collaboration allows Midi Health patients to leverage a three-minute cognitive test developed by Neurotrack, named the Symbol Match test, which can be taken online using any device. Midi Health practitioners can recommend this test to help differentiate between brain fog related to menopause and more serious cognitive disorders such as Alzheimer’s. Depending on the test outcomes, patients can either be referred for additional cognitive condition treatments or manage brain fog under the guidance of their Midi Health practitioner through dietary changes, lifestyle modifications, or medication.</p>
 
</div>

All Updates